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EgyptAbstract Background: Dyspepsia is a common clinical problem. More than half of patients pre-
senting with dyspepsia have no detectable lesion for their symptoms. The common organic causes of
dyspepsia include peptic ulcer, esophagitis and cancer. The diagnostic test of choice is endoscopy.
Age speciﬁc thresholds to trigger endoscopic evaluation may differ by gender, availability of
resources and regional disease speciﬁc risks.
Aim: The aim of the study was to determine the prevalence of signiﬁcant endoscopic lesions in
Egyptian patients presenting with dyspepsia in relation to age.
Materials and methods: This was a retrospective study. Data on patients presenting with dyspepsia
and scheduled for upper gastrointestinal (UGI) endoscopy between January 2000 and January 2013
were collected.
Results: One thousand four hundred patients with dyspepsia (31% of all endoscopies) were
assessed by UGI endoscopy. Fifty-one percent were male. The mean age was 43 ± 15 years. Four
hundred and ﬁfty patients (32%) had a history of smoking, 388 (32%) were taking aspirin or
non-steroidal anti-inﬂammatory drugs and 22 (2%) were consuming alcohol. Endoscopy revealed
normal ﬁndings or miscellaneous irrelevant ﬁndings in 913 patients (65%). Signiﬁcant endoscopic
ﬁndings were diagnosed in 487 (35%). These included peptic ulcers in 245 patients (18%), esopha-
gitis in 191 (14%), erosive gastroduodenitis in 112 (8%) and UGI malignancy in 16 (1%).
Signiﬁcant endoscopic ﬁndings were associated with increasing age.
180 A. Gado et al.Conclusion: Dyspepsia is a common indication for endoscopy in Egypt. Endoscopy revealed nor-
mal ﬁndings or miscellaneous irrelevant ﬁndings in the majority of patients. The most frequent sig-
niﬁcant pathologies included peptic ulcer, esophagitis and erosive gastroduodenitis. These were
associated with increasing age. UGI malignancy was uncommon and found in older age groups.
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reserved.1. Introduction
Dyspepsia is deﬁned as pain or discomfort in the upper abdo-
men.1 It is a common disorder with a prevalence of up to 40%
in the general population in Great Britain.2 More than half of
these patients presenting with dyspepsia have no detectable
cause for their symptoms.1 The common organic causes of
dyspepsia are peptic ulcer, esophagitis and cancer.
Options for evaluating dyspeptic patients include therapeu-
tic trials, testing for Helicobacter pylori, upper gastrointestinal
(UGI) radiography, and endoscopy.3–5 Once the decision has
been made to investigate, the diagnostic test of choice is endos-
copy.1 Patients in whom investigations have revealed no
organic cause are classiﬁed as having functional dyspepsia or
‘‘non-ulcer dyspepsia’’.6
Cancer of the UGI tract is usually advanced at the time of
diagnosis but a low threshold of suspicion for gastric malig-
nancy in dyspeptic patients may result in earlier diagnosis
and improved survival. However cancer accounts for only
1–2% of diagnoses at UGI tract and less in patients under
the age of 50 years.7 Age speciﬁc thresholds to trigger endo-
scopic evaluation may differ by gender, availability of
resources and regional disease speciﬁc risks.8
This study was undertaken to determine the prevalence of
signiﬁcant endoscopic lesions in Egyptian patients presenting
with dyspepsia in relation to age.
2. Materials and methods
This was a retrospective study carried out at Bolak Eldakror
Hospital over a 13-year period from January 2000 to January
2013. Bolak Eldakror Hospital is a secondary-care govern-
mental hospital in Giza, Egypt. The hospital serves an area
of nearly one million population. The gastrointestinal endos-
copy unit was set up in 1999. The endoscopy unit provides an
open-access service and receives patients from outpatient
clinics and other hospitals in the area. Patients are from a
lower socioeconomic background. All patients presenting
with dyspepsia were included in the study. Ten gastroenterol-
ogists performed all endoscopies. Two UGI ﬁberscopes and
two videoscopes (Olympus GIF-E and GIF-Q230) were used.
Endoscopic biopsy was done at the discretion of the endosco-
pist. Pathological examination was performed by two expert
pathologists.
2.1. Deﬁnitions
Dyspepsia was deﬁned as epigastric discomfort, burning sensa-
tion or pain persisting for more than three months.9 Heartburn
is not included in the diagnostic symptom criteria for dyspep-
sia. It is thought to arise primarily from the esophagus beingcaused by gastro-esophageal reﬂux disease although it may
occur concomitantly with dyspeptic symptoms.8
Signiﬁcant endoscopic ﬁndings in the UGI tract were
deﬁned as those beneﬁting from speciﬁc treatment or those
that are life threatening.10 The presence of any of the follow-
ing lesions was considered as a signiﬁcant ﬁnding in UGI
endoscopy: peptic ulcer, esophagitis (with or without hiatal
hernia), erosive gastritis or duodenitis, stricture, Barrett’s
esophagus, esophageal candidiasis, neoplasm, mass and
polyps.
Reﬂux esophagitis was graded according to the Savary–
Miller grading.11,12 Stage I: Erythematous or erythemato-
exudative erosion (alone or multiple, not conﬂuent). Stage
II: conﬂuent but not circumferential erosion. Stage III: cir-
cumferential erosive and exudative lesions. Stage IV: chronic
lesions (ulcer, stenosis). The presence of any of the following
lesions was considered as an irrelevant endoscopic ﬁnding:
erythematous gastritis, atrophic gastritis and incidental
miscellaneous abnormalities (varices, portal hypertensive
gastropathy, hiatal hernia without esophagitis and vascular
ectasia).
2.2. Patients and exclusions
A total of 4477 patients underwent UGI endoscopy between
January 2000 and January 2013. Data on patients presenting
with dyspepsia and scheduled for UGI endoscopy were col-
lected. Patients who underwent UGI endoscopy for reasons
other than dyspepsia such as dysphagia, UGI bleeding, or
strong suspicion of cancer were excluded from the study.
Patients with prior peptic ulcer were also excluded. Those
whose procedures were not completed were excluded
subsequently.
2.3. Data recording and statistics
Patients were stratiﬁed into three groups according to their
age: less than 30 years (group 1), 30–50 years (group 2) and
more than 50 years (group 3).1
A standardized data collection form (sheet) was completed
for each patient. Recorded information included demographic
data (age and gender), smoking history, drugs used (aspirin
and non-steroidal anti-inﬂammatory) alcohol consumption,
associated heartburn, endoscopic ﬁndings and histopathology.
Data were analyzed to assess a statistically signiﬁcant differ-
ence between the age groups for various gastrointestinal
lesions. The data from the patients were registered, tabulated
and statistically analyzed using the Statistical Package for
Social Sciences (SPSS) program version 15 to calculate fre-
quencies and the v2 test. P value was taken as signiﬁcant at a
level less than 0.05.
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One thousand four hundred patients presenting with dyspepsia
were assessed. Dyspepsia was the commonest indication for
UGI endoscopy (Table 1). Percentage of patients with dyspep-
sia who underwent UGI endoscopy among the studied years
ranged from 19% to 56% (mean 31 ± 13).
3.1. Patients’ characteristics
Seven hundred and seven patients (51%) were male and 693
(49%) female. Ages ranged from 18 to 88 years, mean
43 ± 15 years. Four hundred and ﬁfty patients (32%) had a
history of smoking, 388 (32%) were taking aspirin or non-
steroidal anti-inﬂammatory drugs (NSAIDs) and 22 (2%) were
consuming alcohol. One hundred and eighty-three patients
(13%) had associated heartburn. Patients’ characteristics strat-
iﬁed by age are presented in Table 2.
3.2. Endoscopic ﬁndings
Endoscopy revealed normal ﬁndings or miscellaneous irrele-
vant ﬁndings in 913 patients (65%). Endoscopy revealed signif-
icant pathology in 487 patients (35%). Peptic ulcer was
diagnosed in 245 patients (18%), duodenal ulcers in 206
(15%) and gastric ulcers in 57 (4%). Esophagitis was diag-
nosed in 191 patients (14%), stage I in 183 (96%), stage II in
six (3%) and stage III in two (1%). Esophagitis was diagnosed
in 33 patients (18%) who had dyspepsia with heartburn and in
158 patients (13%) without heartburn (P> 0.05, non-signiﬁ-
cant). Grading of esophagitis in patients with and without
heartburn is shown in Figure 1. Erosive gastritis and/or duode-
nitis were diagnosed in 112 patients (8%), gastric erosions in
60 (4%) and duodenal erosions in 67 (5%). Gastric malignancy
was diagnosed in 15 patients (1%) and duodenal cancer in one
(0.1%). Histopathology revealed adenocarcinoma in seven
patients (44%), anaplastic carcinoma in three (19%), undiffer-
entiated carcinoma in three (19%), mucoid carcinoma in one
(6%), lymphoma in one (6%) and malt lymphoma in oneTable 1 Indications for UGI endoscopy among studied years.
Indication* Incidence N (%)
Dyspepsia 1400 (31)
UGI bleeding 1155 (26)
Banding or sclerotherapy of varices 897 (20)
Reﬂux symptoms 433 (10)
Persistent vomiting of unknown cause 285 (6)
Iron deﬁciency anemia 106 (2)
Dysphagia 55 (1)
Check gastric ulcer for healing 18 (0.4)
Removal of foreign body 8 (0.2)
Chronic diarrhea 7 (0.2)
Others 112 (3)
Nonstandard indication** 320 (7)
Total number of cases = 4477.
* Many patients had more than one indication.
** Indication not listed in the American Society of Gastrointestinal
Endoscopy guidelines e.g., follow up of duodenal ulcer or esopha-
gitis and search for primary in patient with metastasis.(6%). Esophageal candidiasis was diagnosed in nine (0.6%)
patients, gastric polyps (hyperplastic) in six (0.4%), Barrett’s
esophagus (4 conﬁrmed by pathology) in ﬁve (0.4%), esopha-
geal stricture in two (0.1%) and submucosal mass (leiomyoma)
in one (0.1%). Many patients had more than one lesion. Biop-
sies were obtained for histopathological examination in 37
patients (3%), mainly in patients with suspicion of malignancy
(swelling or gastric ulcer), Barrett’s esophagus and polyps.
Testing for Helicobacter pylori infection by rapid urease test
was performed in 56 patients with gastric or duodenal ulcer
(4%) and the test was positive in 29 (52%).
Relative frequency of endoscopic ﬁndings in patients pre-
senting with dyspepsia stratiﬁed by age is presented in Table 3.
The prevalence of UGI malignancy among patients with dys-
pepsia in relation to age is presented in Figure 2.4. Discussion
Dyspepsia is a common clinical problem seen by both primary
care physicians and gastroenterologists. Dyspepsia accounts
for about 4–5% of all the general practitioner consultations
and 20–40% of all gastroenterological consultations.13 Initial
evaluation should focus on the identiﬁcation and treatment
of potential causes of symptoms such as gastro-esophageal
reﬂux disease, peptic ulcer disease, and medication side effects
but also on recognizing those at risk for more serious condi-
tions such as gastric cancer. Endoscopy is recommended as
the ﬁrst investigation in the work up of a patient with dyspep-
tic symptoms and is essential in the classiﬁcation of the
patient’s condition as organic or functional dyspepsia.
Approximately 40% of dyspeptic patients have an organic
cause, and only 20% of patients have signiﬁcant gastroduode-
nal lesions, such as peptic ulcer.10,14,15 The most commonly
reported major endoscopic abnormalities are: gastric ulcer
(1.6–8.2%), duodenal ulcer (2.3–12.7%), esophagitis (0–
23.0%), and gastric malignancy (0–3.4%).16 Only in a few
cases are dyspeptic symptoms caused by gastro-esophageal
malignancy.17 While gastric or esophageal cancer is an unusual
ﬁnding in patients with dyspepsia, excluding malignancy is a
common reason given for performing endoscopy.8 Once an
organic cause for symptoms has been excluded, a diagnosis
of functional dyspepsia can be made.8
In the present study 1400 patients presenting with dyspepsia
at a community hospital over a 13-year period were assessed.
Our goal was to describe patients’ characteristics and endo-
scopic ﬁndings among patients with dyspepsia. We focused
on the etiology of dyspepsia in relation to age.
Dyspepsia was the commonest indication for UGI endos-
copy in our institution (31% of all endoscopies). The relative
frequencies of upper endoscopic ﬁnding stratiﬁed by age dem-
onstrated that non-ulcer dyspepsia and signiﬁcant lesions (pep-
tic ulcer, esophagitis and erosive gastroduodenitis) were
common in all age groups (Table 3). Peptic ulcer, esophagitis
and erosive gastroduodenitis were associated with increasing
age (Table 3). UGI malignancy was an uncommon ﬁnding
and found in older age groups (Table 3). The low prevalence
of serious lesions in young patients is consistent with prior
published data.18–20 The number of patients with other signif-
icant lesions (esophageal candidiasis, gastric polyps (hyper-
plastic), Barrett’s esophagus, esophageal stricture and
leiomyoma) is too small for meaningful comparison.
Table 2 Patients’ characteristics stratiﬁed by age.*
Characteristics Group 1 N= 351 Group 2 N= 633 Group 3 N= 416 P value
Age (mean ± SD) 25 ± 4 41 ± 6 61 ± 7 –
Male/female 0.8/1 1/1 1.4/1 –
History of smoking 84 (24%) 210 (33%) 156 (38%) 0.001
Aspirin and NSAIDs intake 82 (23%) 171 (27%) 135 (32%) 0.019
Alcohol consumption 7 (2%) 11 (2%) 4 (1%) 0.467
Heartburn 41 (12%) 85 (13%) 57 (14%) 0.527
* Age groups: group 1 = less than 30 years; group 2 = 30–50 years; group 3 = more than 50 years.
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Figure 1 Degree of esophagitis in patients with dyspepsia with
and without reﬂux symptoms.
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Figure 2 UGI malignancy among patients with dyspepsia in
relation to age.
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evant ﬁndings in 65% of patients presenting with dyspepsia
and 82% of patients younger than 30 years. The ﬁndings of
the present study conﬁrmed that the majority of patients with
dyspepsia had no important endoscopic lesions. Many dyspep-
tic patients continue to be sent for endoscopic evaluation as
the initial step in management. The ﬁndings of the present
study support selective UGI endoscopy in patients with dys-
pepsia because the prevalence of important lesions was very
low in young patients. Further study is warranted to determine
whether young patients with dyspepsia beneﬁt from endos-
copy. Unmeasured beneﬁts could include improvement in
quality of life, if anxiety is reduced, and reduction in subse-
quent health care utilization.Table 3 Endoscopic ﬁndings stratiﬁed by age.*
Endoscopic ﬁndings Group 1 N= 351 (%) G
Normal/irrelevant ﬁndings 288 (82) 39
Signiﬁcant endoscopic ﬁndings
Peptic ulcer 30 (9) 11
Esophagitis 30 (9) 99
Erosive gastroduodenitis 15 (4) 52
UGI malignancy 0 (0.0) 6
Esophageal candidiasis 0 (0.0) 4
Gastric polyps (hyperplastic) 0 (0.0) 2
Barrett’s esophagus 1 (0.3) 1
Esophageal stricture 0 (0.0) 1
Submucosal mass (leiomyoma) 0 (0.0) 0
* Age groups: group 1 = less than 30 years; group 2 = 30–50 years; grSigniﬁcant pathology was diagnosed in 35% of patients
presenting with dyspepsia. The commonest included peptic
ulcer, esophagitis and erosive gastroduodenitis which were
diagnosed in 18%, 14% and 8% of patients, respectively.
These ﬁndings were more frequent among the older age groups
than in the younger age group (P= 0.000, 0.002 and 0.012,
respectively). Esophagitis was more common in those with
reﬂux symptoms than in those without (18% vs. 13%)
(P> 0.05, non signiﬁcant). Esophagitis was of mild grade in
patients presenting without reﬂux symptoms (Figure 1).
We have detected 16 (1%) patients with UGI malignancy
among patients with dyspepsia. Ages ranged from 37 to
75 years. UGI malignancy was diagnosed in 1% of patients
aged 30–50 years and 2% of patients more than 50 yearsroup 2 N= 633 (%) Group 3 N= 416 (%) P value
8 (63) 227 (55) 0.000
6 (18) 99 (24) 0.000
(16) 62 (15) 0.002
(8) 45 (11) 0.012
(1) 10 (2) 0.003
(0.6) 5 (1.2) 0.136
(0.3) 4 (1) 0.114
(0.2) 3 (0.7) 0.299
(0.2) 1 (0.2) 0.704
(0.0) 1 (0.2) 0.306
oup 3 = more than 50 years.
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patients younger than 30 years old. Studies showed the inci-
dence and risk of gastric malignancy steadily increase with
age after 40 years with its highest peak in the seventh decade.21
Figure 2 suggests the same pattern in our sample. No cases of
esophageal cancer were reported in this study because most
patients with esophageal cancer initially present with dyspha-
gia and these patients were excluded from the study. All cases
with UGI malignancy were referred to the National Cancer
Institute for further management but unfortunately majority
was diagnosed at an advanced stage (unpublished). The factors
responsible for delay in detection are underuse of diagnostic
tests, late referrals for UGI endoscopy, misdiagnosis and inju-
dicious use of acid suppression therapy. Perhaps the most
important reason for performing diagnostic endoscopy is to
detect gastric cancer at an early stage. However, in its early
stage, gastric cancer presents with symptoms that are often
indistinguishable from those of benign gastric ulceration;
therefore, all patients who are in the age group at risk of gas-
tric cancer should undergo early endoscopy rather than trials
of medical therapy that may delay diagnosis.22
Testing for Helicobacter pylori infection was performed in
56 patients with gastric or duodenal ulcer (4%) and the test
was positive in 29 (52%). The number of patients assessed
for Helicobacter pylori infection was very small for meaningful
comparison. It was reported that the prevalence of Helicobac-
ter pylori infection in Egypt is 90%.23 One study showed that
the seroprevalence of Helicobacter pylori infection in Cairo is
60%, Alexandria 88%, Assiut (urban) 87% and Assiut (rural)
40%.24
The ﬁndings of the present study conﬁrmed that the major-
ity of patients with dyspepsia had no important endoscopic
lesions. The signiﬁcant endoscopic lesions were more frequent
among the older age groups than in the younger age group.
There was a statistically signiﬁcant difference between the
age groups for the presence of peptic ulcer, esophagitis, erosive
gastroduodenitis and UGI malignancy. Our analysis of daily
clinical practice provided valuable information as all consecu-
tive patients of a community hospital in Egypt were included.
Also the data provide an interesting proﬁle of this group of
patients. Limitation of the study included: the study is
retrospective, lack of biopsy sampling in all patients, thereby
missing microscopic esophagitis, non-erosive reﬂux disease,
histologic gastritis as well as Helicobacter pylori infection. Also
alarm symptoms were not assessed.
In conclusion, dyspepsia is a common indication for
endoscopy in Egypt. Endoscopy revealed normal ﬁndings or
miscellaneous irrelevant ﬁndings in the majority of patients.
The most frequent signiﬁcant pathologies included peptic
ulcer, esophagitis and erosive gastroduodenitis. These were
associated with increasing age. UGI malignancy was uncom-
mon and found in older age groups. Patients with recent
onset of dyspepsia who are in the age group at risk of gastric
malignancy should undergo early endoscopy. Endoscopy can
be avoided in most young patients with chronic dyspepsia
because the beneﬁts of endoscopy in these patients are
uncertain.
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